Volume | 270,416 |
|
|||||
News | - | ||||||
Day High | 311.505 | Low High |
|||||
Day Low | 305.60 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Waters Corp | WAT | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
307.66 | 305.60 | 311.505 | 311.30 | 308.35 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
8,588 | 270,416 | US$ 310.33 | US$ 83,918,473 | - | 231.90 - 363.7995 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
18:00:00 | 65,721 | US$ 311.30 | USD |
Waters Corp Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
18.43B | 59.20M | - | 2.96B | 642.23M | 10.85 | 28.70 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Waters News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical WAT Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 296.18 | 316.06 | 293.91 | 306.09 | 459,077 | 15.12 | 5.11% |
1 Month | 345.15 | 346.88 | 288.94 | 318.45 | 385,291 | -33.85 | -9.81% |
3 Months | 320.81 | 363.7995 | 288.94 | 331.73 | 417,385 | -9.51 | -2.96% |
6 Months | 242.32 | 363.7995 | 234.04 | 304.93 | 462,612 | 68.98 | 28.47% |
1 Year | 289.22 | 363.7995 | 231.90 | 287.13 | 503,335 | 22.08 | 7.63% |
3 Years | 307.34 | 428.22 | 231.90 | 313.52 | 415,665 | 3.96 | 1.29% |
5 Years | 214.04 | 428.22 | 154.39 | 270.45 | 451,292 | 97.26 | 45.44% |
Waters Description
Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2020, Waters generated 59% from pharmaceutical customers, 30% from industrial clients, and 11% from academic/government institutions. |